Source: Eur Respir J 2008; 31: 1268-1273
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Gotoh S., Nishimura N., Takahashi O., Shiratsuka H., Horinouchi H., Ono H., Uchiyama N., Chohnabayashi N.. Adrenal function in patients with community-acquired pneumonia. Eur Respir J 2008; 31: 1268-1273

Member's Comments

No comment yet.

Related content which might interest you: Prognostic value of cortisol and adrenocorticotropic hormone (ACTH) in severe community-acquired pneumonia (SCAP) patients Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Adrenal function is related to prognosis in moderate community-acquired pneumonia Source: Eur Respir J 2010; 36: 615-621 Year: 2010 Adrenal insufficiency and relative eosinophilia in critically ill patients with septic shock due to ventilator-associated pneumonia (VAP) Source: Eur Respir J 2006; 28: Suppl. 50, 785s Year: 2006 Thyroid hormones implication in severe community-acquired pneumonia (SCAP): Relationship with survival, outcomes and clinical complications Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 The role of endothelin-1 in hospitalized patients with community-acquired pneumonia. Source: International Congress 2019 – Mechanisms underlying respiratory infection Year: 2019 Effects of systemic steroids in patients with severe community-acquired pneumonia Source: Eur Respir J 2007; 30: 951-956 Year: 2007 Usefulness of serum cortisol in assessment for the severity of community-acquired pneumonia Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia Year: 2011 Severe community-acquired pneumonia Source: Eur Respir Monogr 2016; 74: 101-116 Year: 2016 Critical illness-related corticosteroid insufficiency and community-acquired pneumonia: back to the future! Source: Eur Respir J 2008; 31: 1150-1152 Year: 2008 Hyponatremia in community-acquired pneumonia due to increased vasopressin secretion – impact on mortality Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009 Corticosteroids in severe pneumonia Source: Eur Respir J 2008; 32: 259-264 Year: 2008 Clinical failure in community-acquired pneumonia Source: International Congress 2014 – PG16 Low respiratory tract infections: learning from real clinical cases Year: 2014 Particularities of community-acquired pneumonia in the elderly Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections Year: 2007 Mixed community-acquired pneumonia in hospitalised patients Source: Eur Respir J 2006; 27: 795-800 Year: 2006 Intravenous steroids in the treatment of community-acquired pneumonia (CAP) Source: Eur Respir J 2004; 24: Suppl. 48, 50s Year: 2004 Cardiovascular consequences of community-acquired pneumonia and other pulmonary infections Source: Eur Respir Monogr 2020; 88: 212-228 Year: 2020 Treatment failure of severe and ventilator-associated pneumonia Source: Annual Congress 2012 - PG17 Clinical failure of treatment of respiratory infections Year: 2012 Diagnosing adrenal insufficiency using ACTH stimulation test Source: Eur Respir J, 56 (2) 2001478; 10.1183/13993003.01478-2020 Year: 2020 Diagnosing adrenal insufficiency using ACTH stimulation test Source: Eur Respir J, 56 (2) 2002149; 10.1183/13993003.02149-2020 Year: 2020